• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.85% Nasdaq Up1.56%

    Alexion Pharmaceuticals, Inc. (ALXN)

    163.42 Down 2.65(1.60%) Oct 5, 4:00PM EDT
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.7
    Mean Recommendation (last week):1.8

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:225.33
    Median Target:224.50
    High Target:257.00
    Low Target:186.00
    No. of Brokers:18

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 1, 2015Raymond JamesInitiated Strong Buy
    May 7, 2015NomuraUpgradeNeutralBuy
    Mar 26, 2012Canaccord GenuityInitiated Buy
    Feb 23, 2012UBSUpgradeNeutralBuy
    Feb 10, 2012Robert W. BairdUpgradeNeutralOutperform
    Dec 9, 2011Barclays CapitalInitiated Overweight
    Apr 25, 2011NeedhamDowngradeBuyHold
    Nov 12, 2010Robert W. BairdInitiated Neutral
    Oct 22, 2010JefferiesDowngradeBuyHold
    Jun 3, 2010OppenheimerUpgradePerformOutperform

    More Upgrades & Downgrades for ALXN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy10999

    Data provided by Thomson/First Call

    Currency in USD.